Epilepsy encompasses a group of heterogeneous brain diseases that affect more than 50
million people worldwide. Epilepsy may have discernible structural, infectious, metabolic …

The rapid pace of disease gene discovery has resulted in tremendous advances in the field
of epilepsy genetics. Clinical testing with comprehensive gene panels, exomes, and …

Human epilepsy is a common and heterogeneous condition in which genetics play an
important etiological role. We begin by reviewing the past history of epilepsy genetics, a field …

Epilepsy is a group of disorders characterized by recurrent seizures, and is one of the most
common neurological conditions. The genetic basis of epilepsy is clear from epidemiological …

In last few years there has been rapid increase in the knowledge of epilepsy genetics.
Nowadays, it is estimated that genetic epilepsies include over than 30% of all epilepsy …

Abstract Development in genetic technology has led to the identification of an increasing
number of genes associated with epilepsy. These discoveries will both provide the basis for …

During the last decade, next generation sequencing technologies such as targeted gene
panels, whole exome sequencing and whole genome sequencing have led to an explosion …

Understanding the aetiology of epilepsy is essential both for clinical management of patients
and for conducting neurobiological research that will direct future therapies. The aetiology of …

Epilepsy is one of the most prevalent chronic neurological disorders, afflicting about 3.5–6.5
per 1000 children and 10.8 per 1000 elderly people. With intensive effort made during the …

The term “epilepsy” describes a heterogeneous group of disorders, most of them caused by
interactions between several or even many genes and environmental factors. Much rarer are …